Top compounds associated with response to TPH2


Feature Type Standardized
Nominal ANOVA
mRNA foretinib GDSC1000 pan-cancer AAC 0.056 0.08
mRNA OSU-03012 GDSC1000 pan-cancer AAC 0.059 0.08
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.057 0.08
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.17 0.08
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.055 0.08
mRNA canertinib CTRPv2 pan-cancer AAC -0.062 0.08
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.08
mRNA ELCPK CTRPv2 pan-cancer AAC 0.084 0.08
mRNA parbendazole CTRPv2 pan-cancer AAC 0.052 0.09
Download CSV